Inteligência Artificial: Avanços no Combate Ao Câncer de Pulmão

Gabriel Azevedo dos Santos; Anna Cláudia dos Santos Nobre; Karliane Medeiros Ovidio Vale; Ana Flavia de Souza Timoteo; Paula Gonçalves Serafini

doi:10.36489/saudecoletiva.2025v16i100p17236-17249

Autores/as

Gabriel Azevedo dos Santos Bacharel em Sistemas de Informação (UFRN) https://orcid.org/0009-0003-1795-1574
Anna Cláudia dos Santos Nobre Doutora em Administração (UFRN) https://orcid.org/0000-0003-1351-4265
Karliane Medeiros Ovidio Vale Doutora em Sistemas e Computação (UFRN) https://orcid.org/0000-0001-9845-8156
Ana Flavia de Souza Timoteo Mestra em Gestão da Informação e do Conheci- mento (UFRN) https://orcid.org/0009-0009-6847-9074
Paula Gonçalves Serafini Mestra em Engenharia de Produção (UFRN; SE- NAC) https://orcid.org/0000-0002-0826-353X

DOI:

https://doi.org/10.36489/saudecoletiva.2025v16i100p17236-17249

Palabras clave:

Inteligencia Artificial, Cáncer de Pulmón, Revisión Terciaria, Diagnóstico Médico, Tecnologías en Salud

Resumen

Este estudio tuvo como objetivo identificar los avances de la inteligencia artificial (IA) en la lucha contra el cáncer de pulmón, mediante una revisión terciaria de la literatura. Se utilizó la metodología propuesta por Felizardo et al.⁽¹⁴⁾, compuesta por las etapas de planificación, ejecución y publicación de resultados. Entre septiembre y noviembre de 2024 se analizaron 22 estudios extraídos de las bases de datos PubMed y Web of Science. Los resultados indican que la IA tiene potencial para mejorar el diagnóstico, optimizar recursos y agilizar el inicio de los tratamientos. Sin embargo, aún enfrenta desafíos como la limitada diversidad y calidad de los datos utilizados para el entrenamiento, además de cuestiones éticas relacionadas con la privacidad y la transparencia. Se concluye que, a pesar de estas limitaciones, la IA representa un avance significativo en el abordaje del cáncer de pulmón, recomendándose nuevas revisiones sobre su aplicación en otros tipos de cáncer.

Citas

Wang HR, Jing YH. Research on the Application of Artificial Intelligence in the Development of Biomedicine and Oncology. 2023 Jan 6;68–71.

Kanan M, Alharbi H, Alotaibi N, Lubna Almasuood, Shahad Aljoaid, Alharbi T, et al. AI-Driven Models for Diagnosing and Predicting Outcomes in Lung Cancer: A Systematic Review and Meta-Analysis. Cancers. 2024 Feb 5;16(3):674.

‌3.Santos M de O, Lima FC da S de, Martins LFL, Oliveira JFP, Almeida LM de, Cancela M de C. Estimativa de Incidência de Câncer no Brasil, 2023-2025. Revista Brasileira de Cancerologia [Internet]. 2023 Feb 6;69(1). Available from: https://rbc.inca.gov.br/index.php/revista/article/view/3700/2644

‌4.MINISTÉRIO DA SAÚDE Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) 6a edição revista e atualizada [Internet]. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document/livro_abc_6ed_0.pdf

SBCO [Internet]. Saiba quais casos de câncer de pulmão precisam de cirurgia • SBCO; [citado 11 dez 2024]. Disponível em: https://sbco.org.br/saiba-quais-casos-de-cancer-de-pulmao-precisam-de-cirurgia/

‌6.O’Connor S, Vercell A, Wong D, Yorke J, Fatmah Abdulsamad Fallatah, Cave L, et al. The application and use of artificial intelligence in cancer nursing: A systematic review. European journal of oncology nursing. 2024 Feb 1;68:102510.

Global Cancer Observatory [Internet]. Global Cancer Observatory; [citado 10 dez 2024]. Disponível em: https://gco.iarc.fr/

‌8.Didier AJ, Nigro A, Noori Z, Omballi MA, Pappada SM, Hamouda DM. Application of machine learning for lung cancer survival prognostication—A systematic review and meta-analysis. Frontiers in artificial intelligence. 2024 Apr 5;7.

‌9.Joo MS, Pyo KH, Chung JM, Cho BC. Artificial intelligence-based non-small cell lung cancer transcriptome RNA-sequence analysis technology selection guide. Frontiers in bioengineering and biotechnology. 2023 Feb 15;11.

‌10.Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians [Internet]. 2024 Apr 4;74(3):229–63. Available from: https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21834

‌11.World Health Organization. Cancer [Internet]. World Health Organization. World Health Organization; 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer

‌12.Hsu YC, Tsai YH, Weng HH, Hsu LS, Tsai YH, Lin YC, et al. Artificial neural networks improve LDCT lung cancer screening: a comparative validation study. BMC Cancer. 2020 Oct 22;20(1).

‌13.Lancaster HL, Heuvelmans MA, Oudkerk M. Low‐dose computed tomography lung cancer screening: Clinical evidence and implementation research. Journal of Internal Medicine. 2022 Mar 24;292(1):68–80.

‌14.Felizardo KR, Nakagawa EY, Fabbri SCPF, Ferrari FC. Revisão Sistemática da Literatura em Engenharia de Software: teoria e prática. 1st ed. Elsevier, editor. 2017.

Kitchenham B, Pretorius R, Budgen D, Pearl Brereton O, Turner M, Niazi M, et al. Systematic literature reviews in software engineering – A tertiary study. Information and Software Technology [Internet]. 2010 Aug [cited 2019 Sep 11];52(8):792–805. Available from: https://dl.acm.org/citation.cfm?id=1808650

‌16.Imtiaz S, Bano M, Ikram N, Niazi M. A tertiary study. Proceedings of the 17th International Conference on Evaluation and Assessment in Software Engineering - EASE ’13. 2013;

‌17.Verner JM, Brereton OP, Kitchenham B, Turner M, Niazi M. Systematic literature reviews in global software development: a tertiary study. 2012 May 14;